AB-1009 Gene Therapy (GAA Gene)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AB-1009 Gene Therapy (GAA Gene), covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late Onset Pompe Disease (PROGRESS-GT LOPD) [Phase 1, Phase 2]